ENTITY
SillaJen Inc

SillaJen Inc (215600 KS)

52
Analysis
Health Care • South Korea
SillaJen, Inc. provides medical research and development services. The Company researches and develops treatment of cancer based on genetic recombination virus. SillaJen conducts its business in South Korea and the United States.
more
Exchange Announcement • 15 Sep 2026 14:07

Material Management Information related to Judgment of Investment(Application for IND Approval)(덱시부프로펜주(WS2405)의 ì œ 1상 임상시험 계획 승인 ì‹ ì²­)

Exchange Announcement • 27 Aug 2026 20:00

Extension of overheated short-selling issue designation (subject to extension of restriction on short-selling)

Exchange Announcement • 26 Aug 2026 20:01

Designation of overheated short-selling issues (applied by a restriction on short-selling)

Exchange Announcement • 19 Aug 2026 20:01

Designation of overheated short-selling issues (applied by a restriction on short-selling)

Exchange Announcement • 27 Mar 2026 16:05

Change of CEO

x